Mani, Inc. (TYO:7730)
Japan · Delayed Price · Currency is JPY 1,195.50
+9.00 (0.76%)
Jul 16, 2025, 3:30 PM JST
Mani, Inc. Revenue
Mani, Inc. had revenue of 7.47B JPY in the quarter ending May 31, 2025, a decrease of -3.01%. This brings the company's revenue in the last twelve months to 29.18B, up 5.82% year-over-year. In the fiscal year ending August 31, 2024, Mani, Inc. had annual revenue of 28.51B with 16.44% growth.
Revenue (ttm)
29.18B
Revenue Growth
+5.82%
P/S Ratio
4.00
Revenue / Employee
7.03M
Employees
4,154
Market Cap
116.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2024 | 28.51B | 4.03B | 16.44% |
| Aug 31, 2023 | 24.49B | 4.07B | 19.95% |
| Aug 31, 2022 | 20.42B | 3.23B | 18.77% |
| Aug 31, 2021 | 17.19B | 1.99B | 13.09% |
| Aug 31, 2020 | 15.20B | -3.13B | -17.06% |
| Aug 31, 2019 | Pro | Pro | Pro |
| Aug 31, 2018 | Pro | Pro | Pro |
| Aug 31, 2017 | Pro | Pro | Pro |
| Aug 31, 2016 | Pro | Pro | Pro |
| Aug 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 866.03B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Shionogi & | 438.27B |